[go: up one dir, main page]

ATA344184A - Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid - Google Patents

Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid

Info

Publication number
ATA344184A
ATA344184A AT0344184A AT344184A ATA344184A AT A344184 A ATA344184 A AT A344184A AT 0344184 A AT0344184 A AT 0344184A AT 344184 A AT344184 A AT 344184A AT A344184 A ATA344184 A AT A344184A
Authority
AT
Austria
Prior art keywords
producing
free
new
water
crystal form
Prior art date
Application number
AT0344184A
Other languages
English (en)
Other versions
AT389117B (de
Inventor
Stig Olof Engelbert Lindholm
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ATA344184A publication Critical patent/ATA344184A/de
Application granted granted Critical
Publication of AT389117B publication Critical patent/AT389117B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0344184A 1984-06-25 1984-10-30 Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid AT389117B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (2)

Publication Number Publication Date
ATA344184A true ATA344184A (de) 1989-03-15
AT389117B AT389117B (de) 1989-10-25

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0344184A AT389117B (de) 1984-06-25 1984-10-30 Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid

Country Status (17)

Country Link
US (2) US4739055A (de)
JP (1) JPS6115881A (de)
AT (1) AT389117B (de)
AU (1) AU566814B2 (de)
BE (1) BE900925A (de)
CH (1) CH661045A5 (de)
DE (1) DE3429415A1 (de)
FI (1) FI79107C (de)
FR (1) FR2567124B1 (de)
GB (1) GB2160861B (de)
IL (1) IL73267A (de)
IT (1) IT1224142B (de)
LU (1) LU85616A1 (de)
NL (1) NL8403250A (de)
NZ (1) NZ209962A (de)
PT (1) PT79411B (de)
ZA (1) ZA85910B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体2―〔4―(2―フロイル)ピペラジン―1―イル〕―4―アミノ―6,7―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
HU230382B1 (hu) * 2001-02-24 2016-03-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
CA2810522A1 (en) * 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
JP5906086B2 (ja) * 2008-08-15 2016-04-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fab関連疾患の治療に用いるためのプリン誘導体
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CA2745037C (en) 2008-12-23 2020-06-23 Boehringer Ingelheim International Gmbh Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
AU2010323068B2 (en) 2009-11-27 2015-09-03 Boehringer Ingelheim International Gmbh Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
MX366325B (es) 2010-05-05 2019-07-05 Boehringer Ingelheim Int Terapia de combinacion.
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US8962636B2 (en) 2011-07-15 2015-02-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (de) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin zur verwendung in der behandlung von albuminuria und nierenbedingten erkrankungen
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156532C (de) *
US2969375A (en) * 1961-01-24 Certification of correction
NL54420C (de) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
AU566814B2 (en) 1987-10-29
CH661045A5 (de) 1987-06-30
FR2567124A1 (fr) 1986-01-10
GB2160861B (en) 1987-11-18
FR2567124B1 (fr) 1990-09-21
US4873330A (en) 1989-10-10
BE900925A (fr) 1985-02-15
GB2160861A (en) 1986-01-02
PT79411A (en) 1984-11-01
IT8423292A0 (it) 1984-10-24
JPH0481993B2 (de) 1992-12-25
FI842544A0 (fi) 1984-06-25
NL8403250A (nl) 1986-01-16
DE3429415C2 (de) 1990-05-03
GB8424999D0 (en) 1984-11-07
DE3429415A1 (de) 1986-01-02
IL73267A0 (en) 1985-01-31
FI79107C (fi) 1989-11-10
LU85616A1 (fr) 1985-06-04
FI842544A (fi) 1985-12-26
AU3451084A (en) 1986-01-02
FI79107B (fi) 1989-07-31
NZ209962A (en) 1987-06-30
IT1224142B (it) 1990-09-26
IL73267A (en) 1988-06-30
ZA85910B (en) 1985-09-25
AT389117B (de) 1989-10-25
US4739055A (en) 1988-04-19
JPS6115881A (ja) 1986-01-23
PT79411B (en) 1986-09-15

Similar Documents

Publication Publication Date Title
AT389117B (de) Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
ATA28687A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA267888A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthydridin-derivaten und deren salzen
PT83186A (de) Verfahren zur herstellung einer stabilen modifikation von torasemid sowie arzneimittel enthaltend torasemid
ATA193185A (de) Verfahren zur herstellung von neuen substituierten benzamiden
AT385755B (de) Verfahren zur herstellung von neuen pyrensulfonsaeurederivaten
ATA251585A (de) Verfahren zur herstellung von neuen ethylendiaminmonoamid-derivaten
ATA150782A (de) Verfahren zur herstellung von neuen 4'-jodderivaten von anthracyclinglykosiden
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
ATA101986A (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
AT386197B (de) Verfahren zur herstellung von neuen indolderivaten
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA149286A (de) Verfahren zur herstellung von neuen chinolinderivaten
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA298586A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
ATA72484A (de) Verfahren zur herstellung von neuen benzamid-derivaten
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
PT82393A (de) Verfahren zur herstellung von neuen benzoesaeurederivaten
AT389307B (de) Verfahren zur herstellung von neuen apovincaminolderivaten und ihren saeureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee